Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2006-05-01
|
| Series: | Swiss Medical Weekly |
| Subjects: | |
| Online Access: | https://www.smw.ch/index.php/smw/article/view/611 |
| _version_ | 1811193993838460928 |
|---|---|
| author | AJ Palmer S Roze WJ Valentine JA Ray |
| author_facet | AJ Palmer S Roze WJ Valentine JA Ray |
| author_sort | AJ Palmer |
| collection | DOAJ |
| first_indexed | 2024-04-12T00:18:41Z |
| format | Article |
| id | doaj.art-0bb1675904bb4726841ca3377f634549 |
| institution | Directory Open Access Journal |
| issn | 1424-3997 |
| language | English |
| last_indexed | 2024-04-12T00:18:41Z |
| publishDate | 2006-05-01 |
| publisher | SMW supporting association (Trägerverein Swiss Medical Weekly SMW) |
| record_format | Article |
| series | Swiss Medical Weekly |
| spelling | doaj.art-0bb1675904bb4726841ca3377f6345492022-12-22T03:55:46ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972006-05-01136212210.57187/smw.2006.11337Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in SwitzerlandAJ PalmerS RozeWJ ValentineJA Rayhttps://www.smw.ch/index.php/smw/article/view/611Cost analysiscostsirbesartanmicroalbuminuriaModellingNephropathy |
| spellingShingle | AJ Palmer S Roze WJ Valentine JA Ray Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland Swiss Medical Weekly Cost analysis costs irbesartan microalbuminuria Modelling Nephropathy |
| title | Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland |
| title_full | Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland |
| title_fullStr | Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland |
| title_full_unstemmed | Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland |
| title_short | Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland |
| title_sort | health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes hypertension and renal disease in switzerland |
| topic | Cost analysis costs irbesartan microalbuminuria Modelling Nephropathy |
| url | https://www.smw.ch/index.php/smw/article/view/611 |
| work_keys_str_mv | AT ajpalmer healtheconomicimplicationsofirbesartanplusconventionalantihypertensivemedicationsversusconventionalbloodpressurecontrolaloneinpatiernswithtype2diabeteshypertensionandrenaldiseaseinswitzerland AT sroze healtheconomicimplicationsofirbesartanplusconventionalantihypertensivemedicationsversusconventionalbloodpressurecontrolaloneinpatiernswithtype2diabeteshypertensionandrenaldiseaseinswitzerland AT wjvalentine healtheconomicimplicationsofirbesartanplusconventionalantihypertensivemedicationsversusconventionalbloodpressurecontrolaloneinpatiernswithtype2diabeteshypertensionandrenaldiseaseinswitzerland AT jaray healtheconomicimplicationsofirbesartanplusconventionalantihypertensivemedicationsversusconventionalbloodpressurecontrolaloneinpatiernswithtype2diabeteshypertensionandrenaldiseaseinswitzerland |